A study on pemetrexed-resistant lung cancer cell lines showed that high concentration of miR-124-3p, which was upregulated in BMs in our study, can decrease pemetrexed resistance by inhibiting the FGF2–EGFR pathway [24]. The gene discussed is EGFR; the disease is lung carcinoma.